Monsenso today announces that the board of Directors has decided to call for an Extraordinary General Meeting on January 29th, 2021, where two new members are proposed to be elected for the board.
Monsenso – a leading provider of mobile health solutions for mental health – plans to further strengthen the board by nominating two new professional board members with strong qualifications and competencies to support Monsenso in getting to the next level in the company’s growth journey: Peter Høngaard Andersen, formerly. Managing Director at Innovation Fund Denmark and VP at Lundbeck; Jacob Hahn Michelsen, SVP Private & Public at NNIT A/S.
Current board member Thomas Knudsen has offered to resign from his position on the board at the Extraordinary General Meeting. Thomas has supported Monsenso’s growth for several years from being a university research project spin-out to becoming an international publicly listed company on Nasdaq First North Growth Market Copenhagen. The board and the management of Monsenso would like to thank Thomas Knudsen for his outstanding work. His contributions have been essential in building up the product portfolio, securing the first rounds of financing, supporting the management and finally listing the company.
The new board is planning to constitute itself with Jukka Pertola as the Chairman and Jakob Bardram as the Vice Chairman until the next ordinary Annual General Meeting on April 14, 2021 where Jukka Pertola is expected to resign as the Chairman. Nomination of the new board members in January will help ensure an appropriate introduction, as well as a smooth transition and handover of responsibilities in the period leading up to the Annual General Meeting.
Jukka Pertola commented: ”Since I became a professional board member, I have been lucky to be invited to multiple boards of exciting companies, one of them being Monsenso. However, to address the good corporate governance requirements, I have decided to reduce my number of board positions and chairmanships. We have found an exceptionally strong pair of new board members, who can contribute to bringing Monsenso to the next level. Jacob Hahn Michelsen has extensive experience in pharma- and health-related software and IT, regulatory environment of medical applications and a valuable industry knowhow, while Peter Høngaard brings considerable experience from science and research, pharmaceuticals, neurology, intellectual property rights, innovation and funding.“
To read the Danish version, click here.
For additional information contact:
Bettina van Wylich-Muxoll
Chief Marketing Officer